Literature DB >> 32892296

Heart Health and Behavior Change in HIV-Infected Individuals.

John M Abbamonte1, Nicholas V Cristofari1, Stephen M Weiss1, Mahendra Kumar1, Dushyantha T Jayaweera2, Deborah L Jones3.   

Abstract

Management of cardiovascular disease risk requires many lifestyle changes involving diet, smoking, and exercise. Individuals with arterial plaque are encouraged to adopt these changes to promote longevity through a variety of interventions. This study examined behavioral changes in response to the standard of care after detection of arterial plaque, specifically among HIV-infected cocaine users. 127 individuals (HIV - COC - n = 43, HIV + COC - n = 19, HIV + COC + n = 35, HIV - COC + n = 30) were followed after a standard of care intervention and assessed 1 and 2 years later on a variety of lifestyle (diet, exercise, smoking) and physiological (blood pressure, body mass index, number of arterial plaques) outcomes. Arterial plaque was found to increase over time (b = 0.003, SE = 0.002, p = .031), and a composite measure of cardiovascular disease risk did not change (b = - 0.004, SE = 0.01, p = .548). Following provision of a standard of care cardiovascular risk reduction intervention, important health behaviors related to CVD risk were resistant to change among both those HIV-infected and uninfected and among cocaine users and non-users.

Entities:  

Keywords:  Cocaine; HIV; Health behaviors; Heart disease; Smoking

Mesh:

Year:  2021        PMID: 32892296      PMCID: PMC8466249          DOI: 10.1007/s10461-020-03022-w

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  25 in total

1.  The role of coding time in estimating and interpreting growth curve models.

Authors:  Jeremy C Biesanz; Natalia Deeb-Sossa; Alison A Papadakis; Kenneth A Bollen; Patrick J Curran
Journal:  Psychol Methods       Date:  2004-03

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Effect of smoking on the clinical progression of HIV-1 infection.

Authors:  N Galai; L P Park; J Wesch; B Visscher; S Riddler; J B Margolick
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-04-15

4.  CV RISK - A new relative cardiovascular risk score.

Authors:  Dumitru Zdrenghea; Gabriel Guşetu; Mihnea Zdrenghea; Gabriel Cismaru; Bogdan Caloian; Georgeta Vaidean; Dana Pop
Journal:  Med Hypotheses       Date:  2019-08-12       Impact factor: 1.538

Review 5.  Cigarette smoking and HIV: more evidence for action.

Authors:  Nancy R Reynolds
Journal:  AIDS Educ Prev       Date:  2009-06

6.  Risk factors for heart failure: a population-based case-control study.

Authors:  Shannon M Dunlay; Susan A Weston; Steven J Jacobsen; Véronique L Roger
Journal:  Am J Med       Date:  2009-11       Impact factor: 4.965

Review 7.  Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review.

Authors:  D L Segal; M Hersen; V B Van Hasselt
Journal:  Compr Psychiatry       Date:  1994 Jul-Aug       Impact factor: 3.735

8.  Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.

Authors:  William H Herman; Qing Pan; Sharon L Edelstein; Kieren J Mather; Leigh Perreault; Elizabeth Barrett-Connor; Dana M Dabelea; Edward Horton; Steven E Kahn; William C Knowler; Carlos Lorenzo; Xavier Pi-Sunyer; Elizabeth Venditti; Wen Ye
Journal:  Diabetes Care       Date:  2017-10-11       Impact factor: 19.112

Review 9.  Food prices and obesity: evidence and policy implications for taxes and subsidies.

Authors:  Lisa M Powell; Frank J Chaloupka
Journal:  Milbank Q       Date:  2009-03       Impact factor: 6.237

10.  Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event.

Authors:  Patrizia Steca; Dario Monzani; Andrea Greco; Cristina Franzelli; Maria Elena Magrin; Massimo Miglioretti; Marcello Sarini; Marta Scrignaro; Luca Vecchio; Francesco Fattirolli; Marco D'Addario
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.